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Abstract
Background: Patients who have been successfully treated for an aneurysmal subarachnoid hemorrhage (aSAH)
often retain multiple health complaints, including mood disorders, cognitive complaints, fatigue, and problems with
social participation. These problems are not always fully addressed during hospital visits or in current outcome
measures, such as the modified Rankin score and the Glasgow Outcome Scale. Here, we present the development
of the “Questionnaire for the Screening of Symptoms in aneurysmal Subarachnoid Hemorrhage” (SOS-SAH), which
screens for the self-reported symptoms of patients with mild disabilities.
Methods: During the development of the SOS-SAH we adhered to the PROM-cycle framework for the selection
and implementation of patient-reported outcome measures (PROMs). The SOS-SAH was developed in an iterative
process informed by a literature study. Patients and healthcare professionals were involved in the development
process through participating in a working group, interviews, and a cognitive validation study.
Results and conclusions: Relevant patient-reported outcomes (PROs) were identified for patients with aSAH. The
SOS-SAH was developed primarily using domains and items from existing PROMs and, if necessary, by developing
new items. The SOS-SAH consists of 40 items and covers 14 domains: cognitive abilities, hypersensitivity to stimuli,
anxiety, depression, fatigue, social roles, personality change, language, vision, taste, smell, hearing, headache, and
sexual function. It also includes a proxy measurement for use by family members to assess cognitive functioning
and personality change.
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Key points
- Several symptoms often remain undetected after an
aneurysmal subarachnoid hemorrhage (aSAH). A
disease-specific PROM for aSAH might reveal more
non-spontaneously mentioned symptoms.
- The SOS-SAH was developed to cover relevant PROs
for patients successfully treated after an aSAH.
- The SOS-SAH consists of 40 items covering 14 do-
mains, and an additional section for a proxy
measurement.
Background
An aneurysmal subarachnoid hemorrhage (aSAH) is the
result of a rupture of an intracranial aneurysm resulting
in an accumulation of blood in the subarachnoid space.
The incidence rate is 6.1 per 100,000 person-years [1].
Advances in the management of aSAH have led to a
mortality rate reduction of 17% over the last 30 years
[2–4], meaning the daily functioning and quality of life
of patients who survived an aSAH is therefore becoming
more and more important.
The typical patient suffering an aSAH is relatively
young (mean age 50–55 years), meaning this condition
has a high impact on society through a loss of product-
ive life years [5, 6]. The estimated costs of an aSAH over
a patient’s lifetime are twice as high as the costs of an
ischaemic stroke, mainly caused by the younger age of
patients with aSAH and the higher mortality rate [7].
Approximately half of patients with a successfully
treated aSAH experience problems with memory, mood,
or neuropsychological function, and a third have prob-
lems in societal participation [8–10]. This highlights the
need to measure these problems from a patient’s point
of view using patient-reported outcomes (PROs). These
PROs can be assessed using patient-reported outcome
measures (PROMs), which are questionnaires consisting
of one or multiple items. Healthcare professionals can
use PROMs in clinical practice to focus on a patient’s in-
dividual health status and as an aid in the follow-up care
of patients. PROMs can also be used across multiple pa-
tients for a quality assessment of treatment and for pub-
lic reporting to promote external transparency [11, 12].
A limited number of validation studies have evaluated
PROMs in patients with aSAH [13]. Due to a low level
of evidence for the quality of these PROMs, no evalu-
ation of content validity or unclear phrasing of items,
none of the cited PROMs were deemed suitable for use
in clinical practice. We therefore describe the develop-
ment process of a new PROM, the “Questionnaire for
the Screening of Symptoms in aneurysmal Subarachnoid
Hemorrhage” (SOS-SAH), which was conducted in col-
laboration with patients, healthcare professionals, and
specialists in PROM development. Our aim was to de-
velop a PROM for use in individual patients with aSAH
to guide their follow-up care, especially for those pa-
tients with mild disabilities that have an apparent good
outcome but may suffer from symptoms that they often
do not actively mention.
Methods
Design and setting
This study was conducted in the Netherlands from May
2018 to April 2020. We adhered to the “PROM-cycle”, a
framework with eight steps necessary for the selection
and implementation of PROMs in healthcare [14]. The
first four steps that focus on the development of a
PROM are described: (1) goal setting for the PROM, (2)
selection of important PROs, (3) identification of
PROMs that cover the selected PROs, and (4) the devel-
opment and testing of a PROM. Throughout the devel-
opment process, collaboration with patients and
healthcare professionals was assured through iterative
interactions. The involvement of the different parties
and processes in each step of the PROM-cycle is pre-
sented schematically in Fig. 1.
Scope
The goal of the PROM is to screen individual patients
with mild disabilities who have been successfully treated
for aSAH, since they are prone to undetected symptoms
during their follow-up care. “Mild disabilities” was de-
fined as an outcome on the modified Rankin Scale
(mRS) of 0, 1, or 2. The mRS is a global disability scale
that has an ordinal scale ranging from no residual symp-
toms (score of 0) to severely disabled (score of 5) [15].
The intention was to construct the PROM using (the do-




The working group included a lead researcher (EN), two
researchers experienced with developing PROMs (IA
and PW), a patient who has experienced aSAH (AS, a
member of the patient organization of patients with an
intracranial aneurysm hosted at Radboud university
medical center), and a neurosurgeon (JB). The working
group made the necessary decisions during the develop-
ment process of the SOS-SAH.
Interviews with healthcare professionals
A focus group interview was scheduled with healthcare
professionals involved in the acute in-hospital care, as
well as follow-up and rehabilitation treatment, of pa-
tients with an aSAH, which informed step 1 of the
PROM-cycle (goal setting), step 2 of the PROM-cycle
(selection of PROs), and an exploration of some aspects
of step 4 of the PROM-cycle (development and testing
Nobels-Janssen et al. BMC Neurology          (2021) 21:162 Page 2 of 12
of the PROM). Neurologists, neurosurgeons, rehabilita-
tion physicians, and specialized nurses from different re-
gions in the Netherlands were contacted to participate
in a focus group interview. Five healthcare professionals
(Table 1) participated in the focus group interview, led
by an experienced moderator. As a second step, two in-
dividual interviews were conducted with a neurologist
and with a rehabilitation specialist who could not attend
the focus group interview. The following topics were dis-
cussed: the goal setting for the PROM, the relevant
PROs for patients with an aSAH, the ideal timing for
completion of the PROM, and the best strategy for the
visual representation of the results of the PROM. After-
wards there were no unresolved issues, and a shared
general view of healthcare professionals involved with
the care for patients with aSAH in the hospital setting
was achieved. The semi-structured interviews were re-
corded and transcribed verbatim. A thematic analysis
was performed on the data using ATLAS.ti version
8.4.20. The interviews were coded based on a topic list,
and new topics that emerged during the analysis were
added to this list. Coding was performed independently
by two researchers (EN and IA), and differences in the
codes were discussed by these two researchers until a
consensus was reached. A summary of the interviews
was returned to the participants for comments or
corrections.
Literature search
The literature was screened to identify relevant PROs
for patients with aSAH that could be related to symp-
toms, activities, and participation, according to the Inter-
national Classification of Functioning, Disability, and
Health (ICF) model [16]. This is a framework for de-
scribing and organizing information on functioning and
disability and conceptualizes a person’s level of
Fig. 1 Flowchart of the steps of the PROM-cycle [14] and involved parties and processes in the development of the SOS-SAH. PROs: patient-
reported outcomes; PROMs: patient-reported outcome measures
Nobels-Janssen et al. BMC Neurology          (2021) 21:162 Page 3 of 12
functioning as an interaction between health conditions,
environmental factors, and personal factors.
The validity of the available PROMs for patients after
aSAH was evaluated in a recent systematic review [13].
We used this review to select the PROs and PROMs for
this study. Additionally, we searched PubMed for quali-
tative studies about the outcomes in patients after aSAH
(using a qualitative research filter (MeSH term) and key-
words “subarachnoid hemorrhage” and “outcome”), and
performed a search guided by articles and their refer-
ences previously included in the national guideline.
For all PROs identified in the literature, we searched
for PROMs that captured the outcome and assessed its
content validity (including face validity) and the length
of the questionnaire. Information on structural validity
was used to assess the dimensionality of multi-domain
PROMs. Only unidimensional domains were considered
potentially suitable to be part of the new PROM.
Interviews with patients: round one
Eleven patients from three hospitals in the Netherlands
were interviewed (Table 1) by trained interviewers to
cover step 2 of the PROM-cycle (selection of PROs), and
step 3 of the PROM-cycle (identification and selection of
PROMs). These patients were successfully treated for an
aSAH less than five years ago, and were selected by their
treating physician. They randomly selected patients of
different ages, genders, and mRS outcome scores. The
topics covered in the interviews were: which PROs are
relevant for patients with aSAH, the potential value of
using a PROM in their own healthcare following aSAH
treatment, the acceptable number of questions for the
PROM to keep the questionnaire complete but concise,
and the preference of completing a questionnaire on
paper or online. The goal of the interview was not to
perform an explorative study about all possible PROs ex-
perienced by patients successfully treated for aSAH, but
more specifically to confirm the relevance of previously
detected PROs in the literature and by healthcare profes-
sionals, and to discuss any other relevant PROs. The in-
terviewees were asked about the content and
comprehensiveness of several existing PROMs, i.e., the
domains of the Stroke Specific Quality of Life scale (SS-
QoL) [17], the Cognitive and Emotional Consequences
of Stroke (CLCE-24) [18], the Hospital Anxiety and De-
pression Scale (HADS) [19, 20], the Quality of Life after
Brain Injury scale (QOLIBRI) [21], the Patient-Reported
Outcomes Measurement Information System question-
naire (PROMIS) [22], and the Stroke Impact Scale (SIS)
[23]. These PROMs were selected because they have
been (partly) validated for use in patients with aSAH (as
found in the systematic review [13]) or commonly used
in research studying the outcomes of aSAH.
The interviews were recorded, and a verbatim tran-
script was made. A thematic analysis with a directed ap-
proach was performed based on a topic list guided by
the interview script. The analysis was performed in
ATLAS.ti. Any new themes that emerged during the
analysis were added to this topic list.
Interviews with patients: round two
After developing the preliminary PROM, a cognitive val-
idation study was conducted to evaluate whether the
questions of the SOS-SAH were interpreted in the way
they were intended (step 4 of the PROM-cycle: testing of
the PROM). This enabled the evaluation of whether the




n (%) or median (range)
Patients round two
n (%) or median range
Total number of participants 7 (100%) 11 (100%) 7 (100%)
Function
Medical doctor 6 (85.7%) n.a. n.a.
Nurse practitioner 1 (14.3%) n.a. n.a.
Medical specialty
Neurology 2 (28.6%) n.a. n.a.
Neurosurgery 4 (57.1%) n.a. n.a.
Rehabilitation medicine 1 (14.3%) n.a. n.a.
Age (mean, range) 49 (30–61) 60 (43–86) 53 (25–74)
Gender
Male 4 (57.1%) 5 (45.5%) 4 (57.1%)
Female 3 (42.9%) 6 (54.5%) 3 (42.9%)
modified Rankin Scale score n.a. 2 (0–3) n.a.
Years after aSAH (mean, range) n.a. 3 (1,5-4,0) 3 (1,5-7,0)
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selected (domains of) existing PROMs were suitable for
use in patients with aSAH, and to assess the comprehensi-
bility of any newly formulated items. Patients with a suc-
cessfully treated aSAH who attended the outpatient clinic
were asked to participate. During the interview, the pa-
tients completed the SOS-SAH and shared their thoughts
about the purpose and phrasing of the questions and
about the comprehensiveness of the SOS-SAH [24]. An
interview guide was used for all the interviews, which were
transcribed verbatim. The analysis was performed based
on a topic list and any new issues that emerged during the
analysis were added to this topic list. Based on the results,
the working group made the final decision about the re-
moval or adaptation of unclear items, leading to the final
version of the SOS-SAH.
Results
Goal setting
The main goal of the SOS-SAH is to screen for un-
detected symptoms in individual patients with mild dis-
abilities following their successful treatment for aSAH.
Healthcare professionals stated that complaints and mild
disabilities common in patients with aSAH are not al-
ways recognized during regular hospital visits, in con-
trast to the complaints of patients with higher mRS
values. Patients with mild disabilities may not actively
mention these symptoms during the follow-up consult-
ation, and due to time restraints healthcare professionals
also may not inquire about all of them. This prohibits
potential treatment or therapy. Healthcare professionals
mentioned the following symptoms that might not be
recognized: fatigue, problems with cognitive functioning,
anxiety, depression, barriers in social participation, and
headaches.
According to patients, a PROM might help them to
identify and bring up the topics they want to discuss
during a consultation, as well as providing insight into
which of their complaints might be caused by the aSAH.
However, none of the patients thought that the use of a
questionnaire in their own care would have had a major
impact on the healthcare they received. Despite that, half
of the interviewed patients have the feeling they lacked
something in their follow-up care, such as support or
more timely and regular follow-up appointments.
All interviewed patients and healthcare professionals
were in favor of an additional proxy measurement,
which is a measurement completed by a person close to
the patient. This would facilitate the indirect measure-
ment of certain domains of functioning, which is espe-
cially important in patients with a decreased insight into
their own performance due to brain damage, as can be
the case in patients with aSAH, which was also found to
be relevant in patients with an apparently good
outcome.
Selection of PROs
In the literature, 17 PROs were identified for patients
with aSAH, listed in Table 2 [3, 9, 25–27]. The working
group decided that if the PROs showed a major overlap,
e.g., fatigue and sleep disorders, or post-traumatic stress
disorder and anxiety, only one PRO was to be included
in the PROM. Healthcare professionals and patients con-
sidered cognitive functioning, depression, anxiety, fa-
tigue, social roles, and personality to be the most
important PROs for the SOS-SAH.
The healthcare professionals recommended the addition
of the following to the SOS-SAH: smell, taste, hearing,
headache (but not pain in general), and hypersensitivity to
especially visual and acoustic stimuli (Table 2). Hypersen-
sitivity to stimuli was also frequently mentioned by the pa-
tients. Sexual dysfunction is not frequently mentioned as
an important outcome after aSAH [28], but healthcare
professionals recommended the active exploration of this
outcome, which patients may otherwise be reluctant to
present. The working group excluded PROs that represent
complaints on the functional level, such as mobility and
upper extremity function, since they are not the main
focus of this study (i.e., they are usually detected in regular
assessments and evaluation).
Identification of PROMs
Only a few validation studies have assessed PROMs spe-
cifically for patients with aSAH, and generally these are
of low quality [13]. The most suitable PROM currently
available for patients with aSAH is the SS-QoL [13];
however, this PROM lacks an assessment of content val-
idity, and the assessment of structural validity resulted
in two factors and not the proposed twelve domains that
the SS-QoL aims to measure [13]. This makes the valid-
ity of the separate domain scores questionable. We iden-
tified one disease-specific PROM for patients with
aSAH: the Subarachnoid Haemorrhage Outcome tool
(SAHOT) [29]. The SAHOT consists of 56 items that
patients rate on a three-point scale according to the
change they experienced. Since no direction of change
(better or worse) is incorporated in the answering op-
tions, the working group considered the face validity of
this tool to be insufficient. The development and assess-
ment of its measurement properties were of low quality
[13]. The interpretation of the SAHOT was developed
using a Rasch-based interval analysis (which is based on
item response theory and requires time for a digital ana-
lysis of the answers using Rasch models), which makes it
unfeasible for use in daily practice. The SS-QoL and the
SAHOT were therefore considered unsuitable for inclu-
sion in the current PROM.
Since the validated PROMs for patients with aSAH
were not suitable, we searched the literature for more
generic PROMs to capture the selected PROs. The
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selected PROMs were the CLCE-24 [18], the HADS [19,
20], QOLIBRI questionnaire [21], the PROMIS question-
naires [22], and the SIS [23]. We selected these PROMs
because they are (at least partially) validated for use in
patients with aSAH, have previously been used in re-
search into the outcomes of aSAH, or because they are
broadly accepted PROMs.
Development and testing of the PROM
Number of questions
Both healthcare professionals and patients found 30–40
items to be the acceptable maximum number in the
PROM; despite this, some patients reported that in prac-
tice they would complete the PROM in multiple at-
tempts due to a lack of energy and/or concentration.
The PROM consists of multiple questions addressing
the most important PROs; cognitive functioning, anxiety,
depression, fatigue, and social roles. In order to keep the
SOS-SAH relatively brief, only one or two questions
were used to address the other PROs.
Patients’ preferences
The interviewed patients in general preferred PROMs
that adhere to their actual experiences and feelings, and
preferred positively formulated items; for example, ‘I feel
cheerful’ (HADS) was preferred over ‘I felt worthless’
(PROMIS short form for depression)). Healthcare pro-
fessionals advised the inclusion of a question about the
degree of recovery after the aSAH; however, during pilot
testing, several patients interpreted this question as ask-
ing whether the aneurysm itself was healed, which was
not the aim of the question. Additionally, only one pa-
tient could provide an estimated degree of recovery, be-
cause the concept of general recovery did not capture
the different persisting complaints or because com-
plaints fluctuated daily. The working group therefore
decided not to add this item to the PROM.
Preliminary SOS-SAH
After consensus was reached in the working group, the
SOS-SAH was composed of the HADS, the PROMIS
short form for fatigue, the PROMIS short form for social
Table 2 The selection process of relevant PROs for patients with an aSAH
PROs Identified from literature (L) or added
after interviews with healthcare
professionals or patients (P)
Final PROs used in the
SOS-SAH
Fatigue L Yes





Upper extremity functioning L No
Sleep disorders L No
Problems with sexuality L Yes
Cognitive functioning L Yes
Personality change L Yes
Depression L Yes
Anxiety L Yes
Posttraumatic stress disorder L No
Work and productivity L No
Family roles L No




Hypersensitiviy to stimuli P Yes
Degree of recovery P No
L: literature; P: healthcare professionals or patients; PROs: patient-reported outcomes; SOS-SAH: Questionnaire for Screening of Symptoms in aneurysmal
Subarachnoid Hemorrhage
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roles, a customized PROMIS short form for cognitive
abilities, and 10 questions to cover the other nine PROs
(Table 3). The HADS is a questionnaire that measures
anxiety and depression, with seven questions per domain
[19]. PROMIS HealthMeasures develops item banks for
frequently assessed PROs that are validated for use in
the general population and for persons with chronic dis-
eases. Ideally, these databases are used as computer
adaptive tests (CATs); however, since CATs are not yet
feasible for widespread use in Dutch clinical practice
and because patients with aSAH preferred to complete
the PROM in paper form, we opted to use the short
forms that were created based on the item banks [22].
In the original PROMIS short form for cognitive abil-
ities, the phrase ‘as usual’ was often used in an item (e.g.,
‘my memory has been as good as usual’). Due to the
changes due to the aSAH itself, the reference point ‘as
usual’ can be ambiguous; therefore, the working group
decided to use a previously developed and translated
customized Dutch form, which did not include ‘as usual’.
Finally, we added 10 questions to the SOS-SAH to cover
the nine remaining PROs. The working group rephrased
an item of the QOLIBRI questionnaire, which was devel-
oped for patients with brain injury, for each of these
PROs (the QOLIBRI item: ‘How bothered are you by
problems with seeing or hearing?’).
Proxy measurements in the SOS-SAH
The working group considered proxy measurements
relevant to assess cognitive abilities and changes in per-
sonality, as for these topics it was deemed most essential
to gain an additional perspective. The PROMIS short
form for cognitive abilities was adapted to fit a proxy
perspective, with permission from PROMIS
HealthMeasures.
Measurement protocol of the SOS-SAH
With regard to the timing of the use of the screening in-
strument, healthcare professionals suggested that the
SOS-SAH screening should take place approximately six
weeks after the aSAH treatment, since an early interven-
tion in the case of persistent complaints might be of
benefit to the patient. Some patients experienced deficits
later in their recovery or did not request help at an early
stage after their aSAH, however; therefore, both the
healthcare professionals and patients recommended that
the questionnaire should also be used later in the course
of the aSAH recovery, such as six months after
treatment.
Cognitive validation
Seven patients were interviewed to validate the SOH-
SAH (Table 1). Additionally, we interviewed five family
members to evaluate the proxy questionnaire.
Most of the questions from the existing PROMs were
understood by the patients as intended, with only a few
questions for which one or two patients had a different
interpretation of the question. Most notably, patients
found it hard to distinguish between ‘focusing’ and ‘con-
centrating’ (PROMS short form for cognitive abilities),
while some patients answered the HADS question ‘I can
enjoy a good book or radio or TV program’ (from its de-
pression domain) negatively due to problems with their
sight rather than feelings of depression. As a whole,
however, the cognitive validation did not reveal any
major problems for the content validity of the existing
PROMs included in the SOS-SAH.
The 10 newly formulated items were also mostly
understood as intended. Only one question about per-
sonality change was sometimes interpreted in a broader
way, with patients taking changes of activities into ac-
count alongside personality change. However, these two
may influence each other so this deviation was consid-
ered minor and the question was left unchanged.
Visual presentation
Healthcare professionals preferred a visual presentation
of the SOS-SAH results that could be easily interpreted
at a glance. They considered colored smileys for each
PRO to be a good way to do this: a green smiley for a
good outcome, orange for moderate, and red for a bad
outcome. These categories were defined based on the
cut-off values for the HADS [19] and the cut-off values
for the PROMIS short forms based on T-scores [30]; the
Table 3 Used PROMs to cover the identified PROs
PROs used in the PROM PROMs
Cognitive abilities PROMIS 8-item custom short form
Depression HADS
Anxiety HADS
Fatigue PROMIS 4-item short form
Social roles PROMIS 4-item short form
Hypersensitivity to stimuli Adapted question from the QOLIBRI
Personality change Adapted question from the QOLIBRI
Language Adapted questions from the QOLIBRI
Vision Adapted question from the QOLIBRI
Taste Adapted question from the QOLIBRI
Smell Adapted question from the QOLIBRI
Hearing Adapted question from the QOLIBRI
Headache Adapted question from the QOLIBRI
Problems with sexuality Adapted question from the QOLIBRI
HADS: Hospital Anxiety and Depression scale; PROs: patient-reported
outcomes; PROMs: patient-reported outcome measures; PROMIS: Patient
Reported Outcomes Measurement Information System; QOLIBRI: Quality of Life
after Brain Injury questionnaire
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working group decided the cut-off values for the do-
mains with one or two questions.
Final result and recommended use
The SOS-SAH consists of 40 items covering 14 domains,
with an additional section for a proxy measurement by
family members containing nine items covering the cog-
nitive abilities and personality change domains (Table 4).
The result of the SOS-SAH can be summarized with a
sum score, presented as a colored smiley for each
domain.
It was not possible for the majority of the interviewed
patients to complete the PROM online without help,
due to an inability to use a computer or a lack of energy
to focus on a computer screen. The working group
therefore recommends that, in practice, the PROM is
presented to patients on paper.
The working group advises the following use of the
SOS-SAH: the PROM could be employed multiple times
during a patient’s follow-up care; for example, at six
weeks, six months, and 12months after the aSAH treat-
ment. We advise healthcare professionals to discuss the
results of the SOS-SAH with the patient to clarify
whether the patient actually considers their condition to
be a problem and to discuss whether there is a need for
treatment. We suggest that patients are asked to
prioritize the domains they want to discuss with the
healthcare professional, in order to enhance patient
engagement.
Discussion
We describe the development of the SOS-SAH, a PROM
for patients with successfully treated aSAH but with mild
disabilities. The SOS-SAH screens for symptoms that
often remain undetected because patients often do not ac-
tively mention these symptoms in consultations with
healthcare professionals. The SOS-SAH was developed
using domains and items from existing PROMs, with 10
newly formulated items. The use of existing PROMs offers
the advantage of validated measurement properties, which
increases the general acceptance of a PROM.
It is important to discuss the results of the PROM
with patients. Pre-existing diseases or personal and en-
vironmental factors can influence impairments, limit ac-
tivity, or restrict participation, as described in the ICF
model [16]. These contextual personal and environmen-
tal factors are not captured in the SOS-SAH; therefore,
we advise the healthcare professionals to ask patients for
a clarification of their answers and discuss whether they
would like to receive treatment.
The SOS-SAH covers cognitive complaints, but is not
meant to replace formal cognitive tests. Subjective cog-
nitive complaints are prevalent after subarachnoid
hemorrhage [26]; however, cognitive complaints do not
necessarily correspond with objective cognitive deficits.
Previous research showed that cognitive complaints cor-
relate not only with cognitive deficits, but also with de-
pressive symptoms, anxiety, and coping style [26, 31–33].
Additionally, an aSAH can affect a patient’s ability to
judge their own cognitive abilities [34]; therefore, patient-
reported cognitive complaints may suggest cognitive dys-
functioning, but cannot replace formal neuropsychological
tests. From a patient’s perspective, their own experience of
cognitive impairments in daily life is what is most import-
ant and that is what must be treated. When the SOS-SAH
reveals cognitive complaints, cognitive tests are advocated.
Both the anxiety and depression domains are incorpo-
rated in the SOS-SAH, although it might not be possible
to measure these two as separate constructs. The HADS
is a well-known and widely used health measurement in-
strument for measuring anxiety and depression; how-
ever, multiple studies have revealed it has an unclear
factor structure [35]. The questions of the HADS are de-
signed to avoid items that might arise due to physical ra-
ther than psychological states [36], but our cognitive
validation interviews revealed that patients took physical
symptoms into account while answering two questions
of the HADS. We will evaluate whether this is problem-
atic in future research on the SOS-SAH. Since our pro-
posed use of the SOS-SAH is as a screening instrument
in individual patient care, valuable information is
gathered from the administration of the HADS.
The PROs that are incorporated in the SOS-SAH over-
lap with relevant PROs for patients after an ischemic
stroke [37]; however, the most frequently occurring
problems differ between patients treated for these two
conditions. In patients after a stroke, the functional out-
come is mainly driven by physical limitations due to
focal brain damage, while for patients after an aSAH the
main problems are usually cognitive disturbances, prob-
lems with societal participation, mood disturbances, and
fatigue [37]. As a result of the higher age of patients
after a stroke and the physical handicaps, the implica-
tions of these deficits in daily life might be less pro-
nounced. It has not yet been investigated whether the
clinical outcome of patients after an aSAH is different
from the outcome of young stroke patients.
The results of a recently published systematic review
show that the currently available PROMs are not suffi-
ciently valid for use with patients successfully treated for
aSAH [13], leading us to develop the SOS-SAH. The
SOS-SAH differs from existing PROMs because the con-
tent validity has been evaluated thoroughly, and because
it has been developed as a screening questionnaire and
contains a proxy measurement. Furthermore, the SOS-
SAH covers more topics than the SS-QoL, most notably
anxiety, headache, smell, hearing, taste, and hypersensi-
tivity to stimuli. In comparison with the SAHOT, the
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Table 4 Definite version of the questions of the SOS-SAH
1 I have been able to bring to mind words that I wanted to
use while talking to someone.
Not at all A little bit Somewhat Quite a bit Very
much
2 I have been able to focus my attention. Not at all A little bit Somewhat Quite a bit Very
much
3 I have been able to remember to do things, like take
medicine or buy something I needed.
Not at all A little bit Somewhat Quite a bit Very
much
4 I have been able to think clearly. Not at all A little bit Somewhat Quite a bit Very
much
5 I have been able to remember the name of a familiar
object.
Not at all A little bit Somewhat Quite a bit Very
much
6 I have been able to concentrate. Not at all A little bit Somewhat Quite a bit Very
much
7 I have been able to pay attention and keep track of what
I am doing without extra effort.
Not at all A little bit Somewhat Quite a bit Very
much
8 I have been able to learn new things easily, like
telephone numbers or instructions.
Not at all A little bit Somewhat Quite a bit Very
much
9 In a busy environment I find myself quickly bothered by
excessive stimuli.
Not at all A little bit Somewhat Quite a bit Very
much
10 I feel tense or ‘wound up’. Most of the
time
A lot of the time From time to
time, occasionally
Not at all




Only a little Hardly at all





Yes, but not too
badly
A little, but it
doesn’t worry me
Not at all







14 Worrying thoughts go through my mind. A great deal of
the time
A lot of the time From time to time
but not too often
Only
occasionally
15 I feel cheerful. Not at all Not often Sometimes Most of the
time
16 I can sit at ease and feel relaxed. Definitely Usually Not often Not at all
17 I feel as if I am slowed down. Nearly all the
time
Very often Sometimes Not at all
18 I get a sort of frightened feeling like ‘butterflies’ in the
stomach.
Not at all Occasionally Quite often Very often
19 I have lost interest in my appearance. Definitely I don’t take so
much care as I
should
I may not take
quite as much
care
I take just as
much care as
ever
20 I feel restless as I have to be on the move. Very much
indeed
Quite a lot Not very much Not at all
21 I look forward with enjoyment to things. As much as I
ever did
Rather less than I
used to
Definitely less
than I used to
Hardly at all
22 I get sudden feelings of panic. Very often
indeed
Quite often Not very often Not at all
23 I can enjoy a good book or radio or TV programme. Often Sometimes Not often Very seldom
24 I feel fatigued. Not at all A little bit Somewhat Quite a bit Very
much
25 I have trouble starting things because I am tired. Not at all A little bit Somewhat Quite a bit Very
much
26 How run-down did you feel on average? Not at all A little bit Somewhat Quite a bit Very
much
27 How fatigued were you on average? Not at all A little bit Somewhat Quite a bit Very
much
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SOS-SAH is easier to use because its scores are not
based on a Rasch analysis. Additionally, its face validity
is better since the answer categories in the SAHOT do
not contain the direction of change [13]. We therefore
think that the SOS-SAH is more useful as a screening
questionnaire in individual patient care.
Strengths
The major strength of the development of the SOS-SAH
is our extensive collaboration with patients and different
types of healthcare professionals. Furthermore, the
methodological adherence to the PROM-cycle and
consensus-based standards for the selection of health
Table 4 Definite version of the questions of the SOS-SAH (Continued)
28 I have trouble doing all of my regular leisure activities
with others
Never Rarely Sometimes Usually Always
29 I have trouble doing all of the family activities that I want
to do
Never Rarely Sometimes Usually Always
30 I have trouble doing all of my usual work (include work
at home)
Never Rarely Sometimes Usually Always
31 I have trouble doing all of the activities with friends that I
want to do
Never Rarely Sometimes Usually Always
32 I am a different person than I was before the
(subarachnoid) hemorrhage.
Not at all A little bit Somewhat Quite a bit Very
much
33 How difficult do you find it to hold a conversation? Not at all A little bit Somewhat Quite a bit Very
much
34 How difficult do you find it to follow a conversation? Not at all A little bit Somewhat Quite a bit Very
much
35 How much difficulty do you have with your sight? Not at all A little bit Somewhat Quite a bit Very
much
36 How much difficulty do you have with your sense of
taste?
Not at all A little bit Somewhat Quite a bit Very
much
37 How much difficulty do you have with your sense of
smell?
Not at all A little bit Somewhat Quite a bit Very
much
38 How much difficulty do you have with your hearing? Not at all A little bit Somewhat Quite a bit Very
much
39 How bothered are you by headaches? Not at all A little bit Somewhat Quite a bit Very
much
40 Has the (subarachnoid) hemorrhage affected your sex
life?
Not at all A little bit Somewhat Quite a bit Very
much
Proxy questions for family members
41
My family member is a different person than he/she was
before the (subarachnoid) hemorrhage.
Not at all A little bit Somewhat Quite a bit Very
much
42
My family member has been able to bring to mind words
that he/she wanted to use while talking to someone.
Not at all A little bit Somewhat Quite a bit Very
much
43
My family member has been able to focus his/her
attention.
Not at all A little bit Somewhat Quite a bit Very
much
44
My family member has been able to remember to do
things, like take medicine or buy something he/she
needed.
Not at all A little bit Somewhat Quite a bit Very
much
45
My family member has been able to think clearly. Not at all A little bit Somewhat Quite a bit Very
much
46
My family member has been able to remember the name
of a familiar object.
Not at all A little bit Somewhat Quite a bit Very
much
47
My family member has been able to concentrate. Not at all A little bit Somewhat Quite a bit Very
much
48
My family member has been able to pay attention and
keep track of what he/she is doing without extra effort.
Not at all A little bit Somewhat Quite a bit Very
much
49
My family member has been able to learn new things
easily, like telephone numbers or instructions.
Not at all A little bit Somewhat Quite a bit Very
much
SOS-SAH: Questionnaire for Screening of Symptoms in aneurysmal Subarachnoid Hemorrhage
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status measurement instruments (COSMIN) is a
strength [14, 38]. Lastly, validated PROMs available in
multiple languages were included in the SOS-SAH,
making the adaptation of the PROM for use in different
countries highly feasible.
In qualitative research, data are gathered until data
saturation is reached, and usually a large number of
patients are interviewed to collect all important aspects
of the outcome measure. In the development of the
SOS-SAH, previously published PROs for patients after
aSAH were used. These PROs were discussed in inter-
views with patients and healthcare professionals to
decide on their relevance and whether they should be in-
cluded in the SOS-SAH. This approach offers a scientific
but pragmatic method to create a comprehensive overview
of relevant PROs for patients. In doing so, we were able to
interview a limited number of patients but still adhere to
the COSMIN guidelines for PROM development [38].
Limitations
The SOS-SAH does not cover all PROs that are import-
ant for patients with an aSAH, such as mobility and
upper extremity function. This decision was made con-
sciously in order to focus on undetected complaints and
limit the length of the questionnaire. Additionally, we
developed the SOS-SAH as a screening instrument for in-
hospital care. The potential value of the SOS-SAH for use
in other settings such as primary care or in the rehabilita-
tion setting might be interesting for future research.
The optimal way of scoring PROMIS short forms is by
the calculation of T-scores based on response pattern
scoring instead of the T-scores in table form that we used.
In response pattern scoring, the T-scores are calculated
based on item parameters, i.e., item difficulty and discrim-
ination of the item. It is only possible to accomplish this
with an online scoring service in which all answers must
be uploaded, which is less feasible in clinical practice.
Finally, the PROM has not yet been clinically tested, and thus
is not yet validated. A validation study was recently begun.
Conclusions
The development of a PROM for implementation in
clinical practice for patients after an aSAH is described
here. It resulted in the “Questionnaire for the Screening
of Symptoms in aneurysmal Subarachnoid Hemorrhage”
(SOS-SAH), which screens for self-reported symptoms
of patients with mild disabilities. The SOS-SAH contains
14 domains and 40 items, in addition to a proxy meas-
urement of nine items covering two domains.
We started a pilot study to test the feasibility of the
SOS-SAH in daily clinical care to gather information
about its practical use, to explore whether the informa-
tion obtained from the SOS-SAH helps physicians and/
or patients, and to determine its measurement
properties.
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